ESC 365 - Transcatheter versus surgical aortic valve replacement in patients with prior cardiac surgery in the randomized PARTNER 2A Trial

ESC Premium Access

Transcatheter versus surgical aortic valve replacement in patients with prior cardiac surgery in the randomized PARTNER 2A Trial

Session: The moving target of strategy selection in severe aortic stenosis

Topic: Intervention

Speaker: Doctor B. Redfors (Goteborg, SE)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Bjorn Redfors

Sahlgrenska Academy - University of Gothenburg, Goteborg (Sweden)

0 follower

3 more presentations in this session

Heart Team decision making in severe aortic stenosis - State of the art

Speaker: Professor J. Chambers (London, GB)

Transcatheter aortic valve implantation futility risk model: insight on a national registry

Speaker: Doctor O. Zusman (Tel Aviv, IL)

In which patients does surgical aortic valve replacement remain the standard?

Speaker: Professor M. Borger (Leipzig, DE)

Access the full session

The moving target of strategy selection in severe aortic stenosis

Speakers: Doctor B. Redfors, Professor J. Chambers, Doctor O. Zusman, Professor M. Borger

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by